PRNewsWire · ULCC · November 12, 2026

Kazia Therapeutics to Host Virtual Event on December 2, 2026: Advancing a New Frontier in Oncology with a First-in-Class Nuclear PD-L1 Protein Degrader

Get the app for more

Explore stock news, insights and company research.